Top

American Journal of Clinical Dermatology

Published in:

Open Access 01-10-2020 | Atopic Dermatitis | Review Article

Efficacy of Nonprescription Moisturizers for Atopic Dermatitis: An Updated Review of Clinical Evidence

Authors: Adelaide A. Hebert, Frank Rippke, Teresa M. Weber, Noreen Heer Nicol

Published in: American Journal of Clinical Dermatology | Issue 5/2020

Abstract

Twice-daily moisturization is recommended by international guidelines as the bedrock of the management of atopic dermatitis (AD). Moisturizers should be selected based on proven clinical effectiveness in improving the skin barrier and improving the symptoms of AD. We searched the PubMed database for clinical trials assessing daily moisturization for the treatment of AD published between 2006 and 2019. Studies had to assess the efficacy of commercially available moisturizers using objective measures of corneometry, transepidermal water loss, or incidence of flare as endpoints, and treatments had to be currently available to patients. Clinical studies showed that moisturization (typically twice daily) significantly improved the skin barrier in adults and children with AD. Longer-term flare studies showed that daily moisturization reduced the incidence of flares and extended the time between flares. Proactive moisturization of infants at high risk of developing AD may reduce its manifestation. Therapeutic moisturizers for AD are specifically formulated with ingredients that target symptoms of AD, such as itch, inflammation, or compromised skin barrier. The US FDA requires that any moisturizer available in the USA and claiming to treat AD must contain colloidal oatmeal. Healthcare providers can maximize compliance and outcomes by educating patients on the benefits of liberally applying a therapeutic moisturizer twice daily to support the skin barrier and help reduce the incidence of flares. Specific recommendations should be for clinically tested moisturizers evaluated using objective, validated skin assessments.

National Eczema Association. Atopic Dermatitis: What is atopic dermatitis? https://nationaleczema.org/eczema/types-of-eczema/atopic-dermatitis/. Accessed 19 Aug 2019.

Wollenberg A, Barbarot S, Bieber T, Christen-Zaech S, Deleuran M, Fink-Wagner A, et al. Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I. J Eur Acad Dermatol Venereol. 2018;32(5):657–82.PubMed

Eichenfield LF, Tom WL, Berger TG, Krol A, Paller AS, Schwarzenberger K, et al. Guidelines of care for the management of atopic dermatitis: part 2. Management and treatment of atopic dermatitis with topical therapies. J Am Acad Dermatol. 2014;71(1):116–32.PubMedPubMedCentral

LePoidevin LM, Lee DE, Shi VY. A comparison of international management guidelines for atopic dermatitis. Pediatr Dermatol. 2019;36:36–65.PubMed

Boguniewicz M, Fonacier L, Guttman-Yassky E, Ong PY, Silverberg J, Farrar JR. Atopic dermatitis yardstick: Practical recommendations for an evolving therapeutic landscape. Ann Allergy Asthma Immunol. 2018;120:10–22.PubMed

Mack Correa MC, Nebus J. Management of patients with atopic dermatitis: the role of emollient therapy. Dermatol Res Pract. 2012;2012:836931.

Lindh JD, Bradley M. Clinical effectiveness of moisturizers in atopic dermatitis and related disorders: A systematic review. Am J Clin Derm. 2015;16(5):341–59.

Sirikudta W, Kulthanan K, Varothai S, Nuchkull P. Moisturizers for patients with atopic dermatitis: an overview. J Allergy Ther. 2013;4(4):1–7.

Micali G, Paternò V, Cannarella R, Dinotta F, Lacarrubba F. Evidence-based treatment of atopic dermatitis with topical moisturizers. Giornale It Dermatol Venereol. 2018;153(3):396–402.

10.

Brunner PM, Emerson RO, Tipton C, Garcet S, Khattri S, Coats I, et al. Nonlesional atopic dermatitis skin shares similar T-cell clones with lesional tissues. Allergy. 2017;72(12):2017–25.PubMed

11.

Unger B, Garcet S, Gonzalez J, Dhingra N, da Rosa CJ, Shemer A, et al. An integrated model of atopic dermatitis biomarkers highlights the systemic nature of the disease. J Invest Dermatol. 2017;137:603–13.

12.

Lloyd-Lavery A, Solman L, Grindlay DJC, Rogers NK, Thomas KS, Harman KE. What’s new in atopic eczema? An analysis of systematic reviews published in 2016. Part 2: epidemiology, aetiology and risk factors. Clin Exp Dermatol. 2016;2019(44):363–9.

13.

Pavel AB, Zhou L, Diaz A, Ungar B, Dan J, He H, et al. The proteomic skin profile of moderate-to-severe atopic dermatitis patients shows an inflammatory signature. J Am Acad Dermatol. 2020;82(3):690–9.PubMed

14.

Biagini Myers JM, Sherenian MG, Kyzy AB, Alarcon R, An A, Flege Z, Morgan D, Gonzalez T, Stevens ML, He H, Kroner JW, Spagna D, Grashel B, Martin LJ, Herr AB, Hershey GKK. Events in Normal Skin Promote Early-life Atopic Dermatitis—the MPAACH Cohort. J Allergy Clin Immunol Pract. 2020;S2213–2198(20):30354–8.

15.

van Zuuren EJ, Fedorowicz Z, Christensen R, Lavrijsen A, Arents BWM. Emollients and moisturisers for eczema. Cochrane Database Syst Rev. 2017;2:CD012119.PubMed

16.

Breternitz M, Kowatzki D, Langenauer M, Elsner P, Fluhr JW. Placebo-controlled, double-blind, randomized, prospective study of a glycerol-based emollient on eczematous skin in atopic dermatitis: biophysical and clinical evaluation. Skin Pharmacol Physiol. 2008;21:39–45.PubMed

17.

Na JI, Hwang JS, Park HJ, Kim DH, Park WS, Youn SW, et al. A new moisturizer containing physiologic lipid granules alleviates atopic dermatitis. J Dermatolog Treat. 2010;21(1):23–7.PubMed

18.

Bianchi P, Theunis J, Casas C, Villeneuve C, Patrizi A, Phulpin C, et al. Effects of a new emollient-based treatment on skin microflora balance and barrier function in children with mild atopic dermatitis. Pediatr Dermatol. 2016;33(2):165–71.PubMedPubMedCentral

19.

Hon KL, Pong NH, Wang SS, Lee VW, Luk NM, Leung TF. Acceptability and efficacy of an emollient containing ceramide-precursor lipids and moisturizing factors for atopic dermatitis in pediatric patients. Drugs R D. 2013;13:37–42.PubMedPubMedCentral

20.

Simpson E, Dutronc Y. A new body moisturizer increases skin hydration and improves atopic dermatitis symptoms among children and adults. J Drugs Dermatol. 2011;10(7):744–9.PubMed

21.

Simpson E, Trookman NS, Rizer RL, Preston N, Colón LE, Johnson LA, et al. Safety and tolerability of a body wash and moisturizer when applied to infants and toddlers with a history of atopic dermatitis: results from an open-label study. Pediatr Dermatol. 2012;29:590–7.PubMed

22.

Hon KL, Wang SS, Lau Z, Lee HC, Lee KK, Leung TF, et al. Pseudoceramide for childhood eczema: does it work? Hong Kong Med J. 2011;17:132–6.PubMed

23.

de Lucas R, García-Millán C, Pérez-Davó A, Moreno E, Redondo P. New cosmetic formulation for the treatment of mild to moderate infantile atopic dermatitis. Children (Basel). 2019. https://doi.org/10.3390/children6020017.CrossRefPubMedPubMedCentral

24.

Schario M, Lünnemann L, Stroux A, Reisshauer A, Zuberbier T, Blume-Peytavi U, et al. Children with dry skin and atopic predisposition: daily use of emollients in a participant-blinded, randomized, prospective trial. Skin Pharmacol Physiol. 2014;27:208.PubMed

25.

Weber TM, Herndon JH Jr, Ewer M, Stephens TJ, Flick I, Filbry A, et al. Efficacy and tolerability of steroid-free, over-the-counter treatment formulations in infants and children with atopic dermatitis. J Dermatol Nurses Assoc. 2015;7(1):17–24.PubMedPubMedCentral

26.

Wananukul S, Chatproedprai S, Chunharas A, Limpongsanuruk W, Singalavanija S, Nitiyarom R, et al. Randomized, double-blind, split-side, comparison study of moisturizer containing licochalcone A and 1% hydrocortisone in the treatment of childhood atopic dermatitis. J Med Assoc Thai. 2013;96(9):1135–42.PubMed

27.

Simpson E, Böhling A, Bielfeldt S, Bosc C, Kerrouche N. Improvement of skin barrier function in atopic dermatitis patients with a new moisturizer containing a ceramide precursor. J Dermatolog Treat. 2013;24(2):122–5.PubMed

28.

Seghers AC, Cai SC, Ho MS, Giam YC, Tan L, Grönhagen CM, et al. Evaluation of a pseudoceramide moisturizer in patients with mild-to-moderate atopic dermatitis. Dermatol Ther (Heidelb). 2014;4(1):83–92.PubMedPubMedCentral

29.

Koppes SA, Charles F, Lammers L, Frings-Dresen M, Kezic S, Rustemeyer T. Efficacy of a cream containing ceramides and magnesium in the treatment of mild to moderate atopic dermatitis: a randomized, double-blind, emollient- and hydrocortisone-controlled trial. Acta Derm Venereol. 2016;96:948–53.PubMed

30.

Weber TM, Babcock MJ, Herndon JH Jr, Schoelermann AM, Filbry AW, Scherdin U, et al. Steroid-free emollient formulations reduce symptoms of eczema and improve quality of life. J Drugs Dermatol. 2014;13(5):589–95.PubMed

31.

Angelova-Fischer I, Neufang G, Jung K, Fischer TW, Zillikens D. A randomized, investigator-blinded efficacy assessment study of stand-alone emollient use in mild to moderately severe atopic dermatitis flares. J Eur Acad Dermatol Venereol. 2014;28(Suppl 3):9–15.PubMed

32.

Bomstein Y, Rozenblat S. Treatment of atopic dermatitis with KAM-3008, a barrier-based, non-steroidal topical cream. J Dermatolog Treat. 2015;26(5):426–30.PubMed

33.

Nasrollahi SA, Ayatollahi A, Yazdanparast T, Samadi A, Hosseini H, Shamsipour M, et al. Comparison of linoleic acid-containing water-in-oil emulsion with urea-containing water-in-oil emulsion in the treatment of atopic dermatitis: a randomized clinical trial. Clin Cosmet Investig Dermatol. 2018;11:21–8.PubMedPubMedCentral

34.

Draelos ZD. A pilot study investigating the efficacy of botanical anti-inflammatory agents in an OTC eczema therapy. J Cosmet Dermatol. 2016;15:117–9.PubMed

35.

Wakeman MP. An open-label forearm-controlled pilot study to assess the effect of a proprietary emollient formulation on objective parameters of skin function of eczema-prone individuals over 14 days. Clin Cosmet Investig Dermatol. 2017;10:275–83.PubMedPubMedCentral

36.

Gayraud F, Sayag M, Jourdan E. Efficacy and tolerance assessment of a new type of dermocosmetic in infants and children with moderate atopic dermatitis. J Cosmet Dermatol. 2015;14(2):107–12.PubMed

37.

Simpson EL, Chalmers JR, Hanifin JM, Thomas KS, Cork MJ, McLean WH, et al. Emollient enhancement of the skin barrier from birth offers effective atopic dermatitis prevention. J Allergy Clin Immunol. 2014;134(4):818–23.PubMedPubMedCentral

38.

Stettler H, Kurka P, Kandzora J, Pavel V, Breuer M, Macura-Biegun A. A new topical panthenol-containing emollient for maintenance treatment of childhood atopic dermatitis: results from a multicenter prospective study. J Dermatolog Treat. 2017;28(8):774–9.PubMed

39.

Wirén K, Nohlgård C, Nyberg F, Holm L, Svensson M, Johannesson A, et al. Treatment with a barrier-strengthening moisturizing cream delays relapse of atopic dermatitis: a prospective and randomized controlled clinical trial. J Eur Acad Dermatol Venereol. 2009;23(11):1267–72.PubMed

40.

Åkerström U, Reitamo S, Langeland T, Berg M, Rustad L, Korhonen L, et al. Comparison of moisturizing creams for the prevention of atopic dermatitis relapse: a randomized double-blind controlled multicentre clinical trial. Acta Derm Venereol. 2015;95(5):587–92.PubMed

41.

Ma L, Li P, Tang J, Guo Y, Guo Y, Shen C, Chang J, et al. Prolonging time to flare in pediatric atopic dermatitis: a randomized, investigator-blinded, controlled, multicenter clinical study of a ceramide-containing moisturizer. Adv Ther. 2017;34(12):2601–11.PubMed

42.

McClanahan D, Wong A, Kezic S, Samrao A, Hajar T, Hill E, et al. A randomized controlled trial of an emollient with ceramide and filaggrin-associated amino acids for the primary prevention of atopic dermatitis in high-risk infants. J Eur Acad Dermatol Venereol. 2019;33(11):2087–94.PubMed

43.

Angelova-Fischer I, Rippke F, Richter D, Filbry A, Arrowitz C, Weber T, et al. Stand-alone emollient treatment reduces flares after discontinuation of topical steroid treatment in atopic dermatitis: a double-blind, randomized, vehicle-controlled, left-right comparison study. Acta Derm Venereol. 2018;98(5):517–23.PubMed

44.

Weber TM, Samarin F, Babcock MJ, Filbry A, Rippke F, et al. Steroid-free over-the-counter eczema skin care formulations reduce risk of flare, prolong time to flare, and reduce eczema symptoms in pediatric subjects with atopic dermatitis. J Drugs Dermatol. 2015;14(5):478–85.PubMed

45.

Mengeaud V, Phulpin C, Bacquey A, Boralevi F, Schmitt AM, Taieb A. An innovative oat-based sterile emollient cream in the maintenance therapy of childhood atopic dermatitis. Pediatr Dermatol. 2015;32(2):208–15.PubMed

46.

De Belilovsky C, Roo-Rodriguez E, Baudouin C, Menu F, Chadoutaud B, Msika P. Natural peroxisome proliferator-activated receptor-alpha agonist cream demonstrates similar therapeutic response to topical steroids in atopic dermatitis. J Dermatolog Treat. 2011;22(6):359–65.PubMed

47.

Schachner LA, Hebert AA, Andriessen A, et al. A global review on the risk factors and management of early atopic dermatitis in children ages 0 to 2 years old. J Drugs Dermatol. 2019;18(10):1020–7.

48.

Elias PM, Wakefield JS, Man MQ. Moisturizers versus current and next-generation barrier repair therapy for the management of atopic dermatitis. Skin Pharmacol Physiol. 2019;32:1–7.PubMed

49.

Bhanot A, Huntley A, Ridd MJ. Adverse events from emollient use in eczema: a restricted review of published data. Dermatol Ther (Heidelb). 2019;9(2):193–208.PubMedPubMedCentral

50.

Draelos ZD. Modern moisturizer myths, misconceptions, and truths. Cutis. 2013;91(6):308–14.PubMed

51.

Fowler JF, Nebus J, Wallo W, Eichenfield LF. Colloidal oatmeal formulations as adjunct treatments in atopic dermatitis. J Drugs Dermatol. 2012;11:804–7.PubMed

52.

Abramovits W, Boguniewicz M, Adult Atopiclair Study Group. A multicenter, randomized, vehicle-controlled clinical study to examine the efficacy and safety of MAS063DP (Atopiclair) in the management of mild to moderate atopic dermatitis in adults. J Drugs Dermatol. 2006;5(3):236–44.PubMed

53.

Miller DW, Koch SB, Yentzer BA, Clark AR, O’Neill JR, Fountain J, et al. An over-the-counter moisturizer is as clinically effective as, and more cost-effective than, prescription barrier creams in the treatment of children with mild-to-moderate atopic dermatitis: a randomized, controlled trial. J Drugs Dermatol. 2011;10:531–7.PubMed

54.

Draelos ZD. An evaluation of prescription device moisturizers. J Cosmet Dermatol. 2009;8:40–3.PubMed

55.

Misery L, Santerre A, Batardière A, Hornez N, Nedelec AS, Le Caër F, et al. Real-life study of anti-itching effects of a cream containing menthoxypropanediol, a TRPM8 agonist, in atopic dermatitis patients. J Eur Acad Dermatol Venereol. 2019;33(2):e67–9.PubMed

56.

Ständer S, Augustin M, Roggenkamp D, Blome C, Heitkemper T, Worthmann AC, et al. Novel TRPM8 agonist cooling compound against chronic itch: results from a randomized, double-blind, controlled, pilot study in dry skin. J Eur Acad Dermatol Venereol. 2017;31:1064–8.PubMed

57.

Kolbe L, Immeyer J, Batzer J, Wensorra U, Dieck TK, Mundt C, et al. Anti-inflammatory efficacy of licochalcone A: correlation of clinical potency and in vitro effects. Arch Dermatol Res. 2006;298(1):23–30.PubMed

58.

Kowalska A, Kalinowska-Lis U. 18β-Glycyrrhetinic acid: its core biological properties and dermatological applications. Int J Cosmet Sci. 2019;41(4):325–31.PubMed

59.

Kahraman E, Kaykin M, Bektay HS, Güngör S. Recent advances on topical application of ceramides to restore barrier function of skin. Cosmetics. 2019;6:52.

60.

Vaughn AR, Clark AK, Sivamani RK, Shi VY. Natural oils for skin-barrier repair: ancient compounds now backed by modern science. Am J Clin Dermatol. 2018;19(1):103–17.PubMed

61.

Celleno L. Topical urea in skincare: a review. Dermatol Ther. 2018;31(6):e12690.PubMed

62.

Rawlings AV, Davies A, Carlomusto M, Pillai S, Zhang K, Kosturko R, et al. Effect of lactic acid isomers on keratinocyte ceramide synthesis, stratum corneum lipid levels and stratum corneum barrier function. Arch Dermatol Res. 1996;288(7):383–90.PubMed

63.

Pigatto PD, Bigardi AS, Cannistraci C, Picardo M. 10% urea cream (Laceran) for atopic dermatitis: a clinical and laboratory evaluation. J Dermatol Treat. 1996;7:171–5.

64.

Tanno O, Ota Y, Kitamura N, Katsube T, Inoue S. Nicotinamide increases biosynthesis of ceramides as well as other stratum corneum lipids to improve the epidermal permeability barrier. Br J Dermatol. 2000;143(3):524–31.PubMed

65.

Rippke F, Schreiner V, Schwanitz HJ. The acidic milieu of the horny layer: new findings on the physiology and pathophysiology of skin pH. Am J Clin Dermatol. 2002;3(4):261–72.PubMed

66.

Zink AGS, Arents B, Fink-Wagner A, Seitz IA, Mensing U, Wettemann N, et al. Out-of-pocket costs for individuals with atopic eczema: a cross-sectional study in nine European countries. Acta Derm Venereol. 2019;99(3):263–7.PubMed

67.

Hon KL, Wang SS, Pong NH, Leung TF. The ideal moisturizer: a survey of parental expectations and practice in childhood-onset eczema. J Dermatolog Treat. 2013;24(1):7–12.PubMed

68.

Ridd MJ, Roberts A, Grindlay D, Williams HC. Which emollients are effective and acceptable for eczema in children? BMJ. 2019;367:l5882.PubMed

69.

Basra MK, Salek MS, Camilleri L, Sturkey R, Finlay AY. Determining the minimal clinically important difference and responsiveness of the Dermatology Life Quality Index (DLQI): further data. Dermatology. 2015;230(1):27–33.PubMed

Title: Efficacy of Nonprescription Moisturizers for Atopic Dermatitis: An Updated Review of Clinical Evidence
Authors: Adelaide A. Hebert
Frank Rippke
Teresa M. Weber
Noreen Heer Nicol
Publication date: 01-10-2020
Publisher: Springer International Publishing
Keyword: Atopic Dermatitis
Published in: American Journal of Clinical Dermatology / Issue 5/2020
Print ISSN: 1175-0561
Electronic ISSN: 1179-1888
DOI: https://doi.org/10.1007/s40257-020-00529-9

At a glance: The STEP trials

Springer Medicine

Efficacy of Nonprescription Moisturizers for Atopic Dermatitis: An Updated Review of Clinical Evidence

Abstract

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 5/2020

Cutaneous Manifestations of COVID-19: An Evidence-Based Review

Vitiligo and Melanoma-Associated Vitiligo: Understanding Their Similarities and Differences

Acne Keloidalis Nuchae and the Metabolic Syndrome: A Population-Based Study

Emerging Therapeutic Options for Chronic Pruritus

Progress to Date in Advancing Stratified Medicine in Psoriasis

New and Emerging Targeted Therapies for Vascular Malformations